Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
As attached23-03-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
This is further to our letter dated 8th February, 2021, regarding intimation of schedule of conference call held on 10th February, 2021. We enclosed herewith the transcript of the said conference call.19-02-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of unaudited financial results (standalone and Consolidated) for the quarter and nine months ended December 31, 2020 published in Business Standard (English) and Tarun Bharat (Marathi) newspapers.09-02-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached an investors presentation of Marksans Pharma Limited for Q3 and 9M FY21.08-02-2021
MARKSANS PHARMA LTD. - 524404 - Unaudited Financial Results For The Quarter And Nine Months Ended December 31St, 2020 And Limited Review Reports Thereon
In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results for the quarter and nine months ended December 31st, 2020 (both Standalone and Consolidated) approved by the Board of Directors at its meeting held today i.e. February 8, 2021 along with Limited Review Reports thereon.08-02-2021
MARKSANS PHARMA LTD. - 524404 - Board Meeting Intimation for Notice Of Board Meeting
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2021 ,inter alia, to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Quarter ended 31st December, 2020.28-01-2021